查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1741106

威尔姆氏肿瘤蛋白市场按产品类型、应用、最终用户、检测方法、疾病阶段和地区划分

Wilms Tumor Protein Market, By Product Type, By Application, By End User, By Detection Method, By Disease Stage, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年威尔姆氏肿瘤蛋白市场规模估计为 31.9 亿美元，预计到 2032 年将达到 43.7 亿美元，2025 年至 2032 年的复合年增长率为 4.6%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 31.9亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期：2025-2032年复合年增长率： 4.60% 2032年价值预测 43.7亿美元

威尔姆氏肿瘤蛋白是一种转录因子，在多种癌症的进展中发挥重要作用。它也被证明与化疗抗药性有关。因此，威尔姆氏肿瘤蛋白被认为是开发新型抗癌药物的有希望的标靶。根据NCBI报导，威尔姆氏肿瘤肿瘤蛋白参与染色质重塑复合物，并促进多种基因的表达。它已被证明与多种化疗药物相互作用，包括道诺霉素和Mitoxantron。

市场动态：

预计预测期内，全球癌症患者数量的增加将推动全球威尔姆氏肿瘤蛋白市场的成长。此外，人们对威尔姆氏肿瘤及其治疗和诊断的认识不断提高，也有望推动预测期内全球威尔姆氏肿瘤蛋白市场的成长。根据美国癌症协会 2020 年 1 月发布的数据， 威尔姆氏肿瘤是儿童最常见的肾癌类型。美国每年报告 500-600 例威尔姆氏肿瘤新病例，这一数字保持相对稳定。 Wilms威尔姆氏肿瘤约占所有儿童癌症的 5%。

然而，预计诊断和治疗程序的高成本将在预测期内阻碍全球威尔姆氏肿瘤威尔姆氏肿瘤市场的成长。诊断和治疗程序的高成本可能会显着阻碍全球威尔姆斯肿瘤蛋白市场的成长。昂贵的诊断测试和治疗可能会限制患者获得治疗，尤其是在医疗资源有限的地区。此类成本障碍可能会降低患者对威尔姆氏肿瘤蛋白相关治疗方法和诊断的接受度，从而可能影响市场扩张，并阻碍其覆盖更广泛患者群体的能力。

本研究的主要特点

  • 本报告对全球威尔姆氏肿瘤蛋白市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。
  • 它还揭示了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 它根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数，介绍了全球威尔姆氏肿瘤蛋白市场的主要企业概况。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球威尔姆氏肿瘤蛋白市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员将透过用于分析全球威尔姆氏肿瘤蛋白市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
  • 针对威尔姆氏肿瘤的标靶治疗需求不断增长
  • 癌症诊断和治疗领域的技术发展
    • 限制因素
  • 诊断和治疗费用高昂
    • 机会
  • 增加对威尔姆氏肿瘤研究的资助
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

4. 全球威尔姆氏肿瘤蛋白市场-冠状病毒（COVID-19）大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 2020 年至 2032 年全球威尔姆氏肿瘤蛋白市场（依产品类型）

  • 抗体
  • 检测试剂套件
  • 重组蛋白
  • 其他的

6. 2020 年至 2032 年全球威尔姆氏肿瘤蛋白市场（依应用）

  • 癌症诊断
  • 癌症治疗
  • 研究与开发
  • 其他的

7. 2020 年至 2032 年全球威尔姆氏肿瘤蛋白市场（依最终用户划分）

  • 医院
  • 诊断实验室
  • 研究所
  • 其他的

8. 2020 年至 2032 年全球威尔姆氏肿瘤蛋白市场（依检测方法）

  • 免疫组织化学（IHC）
  • 酵素免疫分析法（ELISA）
  • 西方印渍术
  • 聚合酵素链锁反应（PCR）
  • 其他的

9. 2020 年至 2032 年按疾病阶段分類的全球威尔姆氏肿瘤蛋白市场

  • 诊断
  • 监测和预测

10. 2020 年至 2032 年全球威尔姆氏肿瘤蛋白市场（按地区）

  • 北美洲
      • 美国
      • 加拿大
  • 欧洲
      • 英国
      • 德国
      • 义大利
      • 法国
      • 西班牙
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • ASEAN
      • 澳洲
      • 韩国
      • 其他亚太地区
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 中东
      • GCC
      • 以色列
      • 其他中东地区
  • 非洲
      • 北非
      • 中部非洲
      • 南非

第十一章竞争格局

  • Abcam plc.
  • Thermo Fisher Scientific, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Novus Biologicals, LLC
  • R&D Systems, Inc.（a subsidiary of Bio-Techne Corporation）
  • OriGene Technologies, Inc.
  • Cell Signaling Technology, Inc.
  • Merck KGaA
  • BioLegend, Inc.
  • Genetex, Inc.（a subsidiary of Novus Biologicals, LLC）
  • Agilent Technologies, Inc.
  • Proteintech Group, Inc.
  • Sino Biological Inc.
  • Boster Biological Technology
  • Fitzgerald Industries International

第十二章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5825

Wilms Tumor Protein Market is estimated to be valued at USD 3.19 Bn in 2025 and is expected to reach USD 4.37 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 3.19 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 4.60% 2032 Value Projection: USD 4.37 Bn

Wilms tumor protein is a transcription factor that plays an important role in the progression of various types of cancer. It has also been shown to be associated with resistance to chemotherapies. As a result, Wilms tumor protein has been proposed to be a promising target for the development of new anti-cancer drugs. According to NCBI, Wilms tumor protein is involved in the chromatin remodeling complex and promotes the expression of several genes. It has been shown to interact with several chemotherapeutic agents including daunorubicin and mitoxantrone.

Market Dynamics:

Increasing cancer cases worldwide is expected to drive growth of the global wilms tumor protein market over the forecast period. Moreover, increasing awareness regarding Wilms tumor and its treatment and diagnosis is also expected to propel growth of the global Wilms tumor protein market over the forecast period. According to the data published by American Cancer Society in January 2020, Wilms tumor stands as the predominant form of kidney cancer found in children. Annually, in the U.S., 500 to 600 new Wilms tumor cases are reported, a figure that has exhibited relatively consistent levels over an extended period. Wilms tumors account for approximately 5% of all childhood cancer cases.

However, high cost of diagnosis and treatment procedures is expected to hinder growth of the global Wilms tumor protein market over the forecast period. The high cost of diagnosis and treatment procedures can significantly hinder the growth of the global Wilms tumor protein market. Expensive diagnostic tests and treatments may limit accessibility for patients, particularly in regions with limited healthcare resources. This cost barrier could reduce patient uptake of Wilms tumor protein-related therapies and diagnostics, potentially impacting the market's expansion and inhibiting the ability to reach a broader patient population.

Key features of the study:

  • This report provides in-depth analysis of the global wilms tumor protein market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global wilms tumor protein market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abcam plc, Thermo Fisher Scientific, Inc., Santa Cruz Biotechnology, Inc., Novus Biologicals, LLC, R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation), OriGene Technologies, Inc., Cell Signaling Technology, Inc., Merck KGaA, BioLegend, Inc., Genetex, Inc. (a subsidiary of Novus Biologicals, LLC), Agilent Technologies, Inc., Proteintech Group, Inc., Sino Biological Inc., Boster Biological Technology, and Fitzgerald Industries International
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global wilms tumor protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global wilms tumor protein market

Global Wilms Tumor Protein Market Detailed Segmentation:

  • By Product Type:
    • Antibodies
    • Assay Kits
    • Recombinant Proteins
    • Others
  • By Application:
    • Cancer Diagnosis
    • Cancer Treatment
    • Research and Development
    • Others
  • By End User:
    • Hospitals
    • Diagnostic Laboratories
    • Research Institutes
    • Others
  • By Detection Method:
    • Immunohistochemistry (IHC)
    • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Western Blotting
    • Polymerase Chain Reaction (PCR)
    • Others
  • By Disease Stage:
    • Diagnosis
    • Monitoring and Prognosis
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Abcam plc
    • Thermo Fisher Scientific, Inc.
    • Santa Cruz Biotechnology, Inc.
    • Novus Biologicals, LLC
    • R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation)
    • OriGene Technologies, Inc.
    • Cell Signaling Technology, Inc.
    • Merck KGaA
    • BioLegend, Inc.
    • Genetex, Inc. (a subsidiary of Novus Biologicals, LLC)
    • Agilent Technologies, Inc.
    • Proteintech Group, Inc.
    • Sino Biological Inc.
    • Boster Biological Technology
    • Fitzgerald Industries International

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Wilms Tumor Protein, By Product Type
    • Market Wilms Tumor Protein, By Application
    • Market Wilms Tumor Protein, By End User
    • Market Wilms Tumor Protein, By Detection Method
    • Market Wilms Tumor Protein, By Disease Stage
    • Market Wilms Tumor Protein, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing demand for targeted therapies for Wilms tumor treatment
  • Technological developments in the field of cancer diagnostics and treatment
    • Restraints
  • High cost of diagnosis and treatment procedures
    • Opportunities
  • Growing funding for research on Wilms tumor
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Wilms Tumor Protein Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Wilms Tumor Protein Market, By Product Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Assay Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Recombinant Proteins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Wilms Tumor Protein Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cancer Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Cancer Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Research and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Wilms Tumor Protein Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Wilms Tumor Protein Market, By Detection Method, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Immunohistochemistry (IHC)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,( US$ Bn)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Western Blotting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Polymerase Chain Reaction (PCR)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Wilms Tumor Protein Market, By Disease Stage, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Monitoring and Prognosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

10. Global Wilms Tumor Protein Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2025-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-Region, 2020-2032, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

11. Competitive Landscape

  • Abcam plc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Santa Cruz Biotechnology, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novus Biologicals, LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • OriGene Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Cell Signaling Technology, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BioLegend, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Genetex, Inc. (a subsidiary of Novus Biologicals, LLC)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Agilent Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Proteintech Group, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sino Biological Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Boster Biological Technology
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Fitzgerald Industries International
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

12. Section

  • Research Methodology
  • About us